LEADER 01298nam  2200433   450 
001 9910812996003321
005 20230807202859.0
010   $a1-910419-36-2
010   $a1-910419-35-4
035   $a(CKB)4330000000072274
035   $a(MiAaPQ)EBC5092541
035   $a(EXLCZ)994330000000072274
100   $a20171109h20152015  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aOptimizing antibody drug conjugates for targeted delivery of therapeutics /$feditor, Norbert Sewald
210  1$aLondon, England :$cFuture Science Ltd,$d2015.
210  4$dİ2015
215   $a1 online resource (191 pages) $cillustrations
225 1 $aFuture Science,$x2047-332X
311   $a1-910419-37-0 
320   $aIncludes bibliographical references.
410  0$aFuture science.
606   $aPharmacokinetics$vCongresses
606   $aPharmacology
615  0$aPharmacokinetics
615  0$aPharmacology.
676   $a615.7
702   $aSewald$b Norbert
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910812996003321
996   $aOptimizing antibody drug conjugates for targeted delivery of therapeutics$94115956
997   $aUNINA